Treatment of malignant glaucoma with intravenous mannitol infusion. Medical reformation of the anterior chamber by means of an osmotic agent: a preliminary report.

D. I. Weiss,R. Shaffer,D. Harrington
DOI: https://doi.org/10.1001/ARCHOPHT.1963.00960040160004
1963-02-01
A M A Archives of Ophthalmology
Abstract:Malignant glaucoma, appropriately so named by von Graefe in 1869, 1 is a dire elevation of intraocular pressure occurring hours, days, or weeks after glaucoma surgery in the shallow-chambered eye with an elevated intraocular pressure, 2 and characterized by absence or extreme shallowing of the anterior chamber and a refractoriness to the usual methods of glaucoma therapy. It is an uncommon complication in which there is a forward movement of the lens-iris diaphragm, probably related to sudden loss of anterior chamber aqueous during or soon after surgery. The posteroanterior flow of aqueous humor is blocked, the aqueous being trapped behind a relatively large lens or pooling within the vitreous or behind a detached vitreous body. 3 Until recently the medical treatment of malignant glaucoma has been useless, even worsening the prognosis by unduly delaying the necessary surgical measures. Posterior sclerotomy and re-formation of the anterior chamber with air or saline
What problem does this paper attempt to address?